TR30

$180.00

Tirzepatide 30mg (Research Chemical)

Dual GLP-1 & GIP Receptor Agonist for Advanced Metabolic Research

Tirzepatide is a next-generation research peptide designed for scientific exploration of metabolic regulation, weight management, and glucose homeostasis. This dual agonist targets both the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors, offering a powerful tool for studying hormonal pathways involved in appetite control, insulin sensitivity, and energy balance.

Key Highlights

  • Potency: Dual GLP-1/GIP receptor agonist

  • Quantity: 60mg lyophilized peptide (1 vial)

  • Purity: >99% (HPLC-verified)

  • Form: Lyophilized powder for reconstitution

  • Research Focus: Obesity, diabetes, insulin sensitivity, metabolic syndrome

Included in Kit

  • 1 x Tirzepatide 30mg vial

  • 1 x 3ml bacteriostatic water (for reconstitution)

  • 1 x 3ml mixing syringe

  • 2 x alcohol wipes

  • General reconstitution guideline (for laboratory use only)

Intended Use & Safety

  • For Research Use Only:
    Not for human or veterinary use. Not intended for diagnostic, therapeutic, or medical treatment purposes.

  • Handling:
    Use in a controlled laboratory setting by qualified professionals. Follow appropriate safety protocols.

  • Storage:
    Store lyophilized peptide at –20°C to –80°C. Protect from light and moisture. Reconstituted solution should be refrigerated and used within research parameters.

Why Tirzepatide 60mg?

With its dual-receptor activity, Tirzepatide represents a breakthrough in the exploration of metabolic modulation. Researchers investigating obesity, type 2 diabetes, and hormone signaling can leverage this high-purity peptide to gain deeper insights into the synergistic effects of GLP-1 and GIP receptor agonism.

Disclaimer: This compound is sold strictly for laboratory research. By purchasing, you agree to use it in accordance with all local laws and research regulations.

Tirzepatide 30mg (Research Chemical)

Dual GLP-1 & GIP Receptor Agonist for Advanced Metabolic Research

Tirzepatide is a next-generation research peptide designed for scientific exploration of metabolic regulation, weight management, and glucose homeostasis. This dual agonist targets both the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors, offering a powerful tool for studying hormonal pathways involved in appetite control, insulin sensitivity, and energy balance.

Key Highlights

  • Potency: Dual GLP-1/GIP receptor agonist

  • Quantity: 60mg lyophilized peptide (1 vial)

  • Purity: >99% (HPLC-verified)

  • Form: Lyophilized powder for reconstitution

  • Research Focus: Obesity, diabetes, insulin sensitivity, metabolic syndrome

Included in Kit

  • 1 x Tirzepatide 30mg vial

  • 1 x 3ml bacteriostatic water (for reconstitution)

  • 1 x 3ml mixing syringe

  • 2 x alcohol wipes

  • General reconstitution guideline (for laboratory use only)

Intended Use & Safety

  • For Research Use Only:
    Not for human or veterinary use. Not intended for diagnostic, therapeutic, or medical treatment purposes.

  • Handling:
    Use in a controlled laboratory setting by qualified professionals. Follow appropriate safety protocols.

  • Storage:
    Store lyophilized peptide at –20°C to –80°C. Protect from light and moisture. Reconstituted solution should be refrigerated and used within research parameters.

Why Tirzepatide 60mg?

With its dual-receptor activity, Tirzepatide represents a breakthrough in the exploration of metabolic modulation. Researchers investigating obesity, type 2 diabetes, and hormone signaling can leverage this high-purity peptide to gain deeper insights into the synergistic effects of GLP-1 and GIP receptor agonism.

Disclaimer: This compound is sold strictly for laboratory research. By purchasing, you agree to use it in accordance with all local laws and research regulations.